Literature DB >> 1421414

Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease.

P Y Dietrich1, A Caignard, A Diu, C Genevee, J L Pico, M Henry-Amar, J Bosq, E Angevin, F Triebel, T Hercend.   

Abstract

T lymphocytes play a pivotal role in graft-versus-host disease (GVHD) and largely contribute to the graft-versus-leukemia (GVL) effect. Most mature T lymphocytes specifically recognize antigens through the alpha/beta T-cell receptor (TCR). Each alpha/beta TCR chain includes a constant region and a variable region, the latter being encoded by V-J alpha or V-D-J beta rearranged gene segments. To better characterize T cells involved in GVHD, V alpha and V beta gene segment usage was analyzed, after cDNA amplification, in peripheral blood mononuclear cells (PBMC) and skin samples from three patients with grade II cutaneous GVHD. At time of GVHD diagnosis (days 11, 22, and 25), when first signs of engraftment were detectable, virtually all V alpha and V beta subfamilies were represented in PBMC RNAs of the three recipients. These results suggest that diversified TCR gene segment expression is observed early after allogenic bone marrow transplantation (alloBMT). Lymphocytes infiltrating GVHD skin also expressed a large series of V alpha and V beta subfamily specificities. However, analysis of the V alpha and V beta amplified products showed substantial differences between PBMC and the skin lymphocyte RNAs. These observations indicate that a large variety of T lymphocytes are present at the disease site, while some of them may be specifically amplified or decreased in response to minor histocompatibility antigens (miHA). Further characterization of the latter T-cell subpopulations should lead to a better understanding of human in vivo responses directed at miHA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1421414

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

Authors:  J Gaschet; A Lim; L Liem; R Vivien; M M Hallet; J L Harousseau; J Even; E Goulmy; M Bonneville; N Milpied; H Vié
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.

Authors:  E J Claret; E P Alyea; E Orsini; C C Pickett; H Collins; Y Wang; D Neuberg; R J Soiffer; J Ritz
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease.

Authors:  Everett H Meyer; Andro R Hsu; Joanna Liliental; Andrea Löhr; Mareike Florek; James L Zehnder; Sam Strober; Philip Lavori; David B Miklos; David S Johnson; Robert S Negrin
Journal:  Blood       Date:  2013-05-07       Impact factor: 22.113

4.  Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease.

Authors:  Gerald P Morris; Geoffrey L Uy; David Donermeyer; John F Dipersio; Paul M Allen
Journal:  Sci Transl Med       Date:  2013-06-05       Impact factor: 17.956

5.  T cell receptor repertoire of CD4+ and CD8+ T cell subsets in the allogeneic bone marrow transplant recipient.

Authors:  F S Smith; S D Rencher; H E Heslop; J L Hurwitz
Journal:  Cancer Immunol Immunother       Date:  1995-08       Impact factor: 6.968

6.  Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance.

Authors:  Patricia E de Almeida; Everett H Meyer; Nigel G Kooreman; Sebastian Diecke; Devaveena Dey; Veronica Sanchez-Freire; Shijun Hu; Antje Ebert; Justin Odegaard; Nicholas M Mordwinkin; Thomas P Brouwer; David Lo; Daniel T Montoro; Michael T Longaker; Robert S Negrin; Joseph C Wu
Journal:  Nat Commun       Date:  2014-05-30       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.